J. Goldman & CO LP Liquidia Corp Transaction History
J. Goldman & CO LP
- $3.21 Billion
- Q3 2024
A detailed history of J. Goldman & CO LP transactions in Liquidia Corp stock. As of the latest transaction made, J. Goldman & CO LP holds 54,000 shares of LQDA stock, worth $851,580. This represents 0.01% of its overall portfolio holdings.
Number of Shares
54,000Holding current value
$851,580% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding LQDA
# of Institutions
174Shares Held
44.4MCall Options Held
1.55MPut Options Held
1.52M-
Patient Square Capital LP Menlo Park, CA7.18MShares$113 Million26.66% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$66.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$54.3 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$51.9 Million0.17% of portfolio
-
Findell Capital Management LLC New York, NY3.19MShares$50.4 Million16.08% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.01B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...